Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Ruud M, Frisk M, Melleby AO, Norseng PA, Mohamed BA, Li J, Aronsen JM, Setterberg IE, Jakubiczka J, van Hout I, Coffey S, Shen X, Nygård S, Lunde IG, Tønnessen T, Jones PP, Sjaastad I, Gullestad L, Toischer K, Dahl CP, Christensen G, Louch WE(2024) Regulation of cardiomyocyte t-tubule structure by preload and afterload: Roles in cardiac compensation and decompensation J Physiol(in press) DOI 10.1113/JP284566, PubMed 38686538
Harwood-Gross A, Nordstrand AE, Bøe HJ, Gjerstad CL(2024) How do you see me? The impact of perceived societal recognition on PTSD symptoms amongst Norwegian peacekeepers Eur J Psychotraumatol, 15(1), 2314442 DOI 10.1080/20008066.2024.2314442, PubMed 38682255
Jacewicz M, Rud E, Lauritzen P, Baco E(2024) Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia BJU Int(in press) DOI 10.1111/bju.16383, PubMed 38679416